Sleep is an essential component of health and wellness; yet, many people experience disruptions in their sleep-wake cycle that are severe enough to impair physiological and psychosocial functioning. Disorders of the sleep-wake cycle, such as obstructive sleep apnea, narcolepsy and hypersomnia, as well as associated syndromes such as cataplexy and excessive daytime sleepiness, represent significant health problems with short- and long-term consequences. Sleep disorders have been associated with metabolic effects, changes in circadian rhythms, proinflammatory responses, and psychiatric, neurologic, pulmonary, and cardiac conditions, as well as decrements in neurocognitive domains. Likewise, sleep disorders can negatively impact work performance and attendance, and may contribute to increased injuries and accidents, creating a significant economic burden, as well as increased health care utilization and more frequent and longer hospitalizations.
Given the significant impact of sleep disorders, the identification and implementation of safe, effective therapies is paramount. The CME Outfitters Sleep Disorders Hub is designed to provide clinicians with the latest clinical practice guidelines, diagnostic strategies and tools, and scientific updates on current and emerging therapies to optimize the management of sleep disorders. In addition, the Sleep Disorders Hub also provides patient education tools to empower patients to make informed decisions about their care.
The final episode of this CMEO BriefCase series on narcolepsy focuses on weighing different treatment plans and optimization, considering CV comorbidities, and individualizing care based on the patient’s lifestyle, QoL, and SDoH. This activity features a panel of experts in the field as well as capturing the patient perspective from the founder of Project Sleep, Julie Flygare.
The first episode of this CMEO BriefCase series on narcolepsy focuses on screening for narcolepsy based on patient presentation, description of function, and changes in QoL to facilitate initiation of a treatment plan to optimize patient outcomes.
Join us for this third of three BriefCase activities in which our expert faculty interweaves foundational knowledge with exercises for HCPs to practice new learnings with a case that emulates a patient with OSA and EDS seen in clinical practice.
The second episode of this CMEO BriefCase series on narcolepsy focuses on distinguishing narcolepsy from other disorders, with expert faculty demonstrating how to choose, implement, and interpret screening and diagnostic tools.
Join us for this second of three BriefCase activities in which our expert faculty interweaves foundational knowledge with exercises for HCPs to practice new learnings with a case that emulates a patient with OSA and EDS seen in clinical practice.
Join us for this first of three BriefCase activities in which our expert faculty interweaves foundational knowledge with exercises for HCPs to practice new learnings with a case that emulates a patient with OSA and EDS seen in clinical practice.
In this CMEO Snack, entitled Managing Cardiovascular Risk in Patients with Narcolepsy, expert faculty will discuss strategies for initiating and switching treatment plans for patients with narcolepsy that consider comorbidities, dosing, and titration strategies.
In this CME Snack, expert faculty will discuss how to better identify the impact of symptoms on QoL and work, school, and/or psychosocial functioning for pediatric and adult patients with narcolepsy.
In this CMEO BriefCase entitled, Choosing Treatment: Matching Needs to Therapy, expert faculty will engage in a case-based discussion on how to best utilize the latest efficacy and safety data to integrate novel therapies into clinical practice to mitigate the impact of IH.
In this CMEO BriefCase, entitled Recognizing IH: The Patient Diagnostic Journey, expert faculty will walk through a case-driven discussion on the significant impact of symptoms on QoL and work/psychosocial functioning for patients with IH, and how this leads to delays in screening and diagnosis.
This CMEO Snack will aid clinicians in overcoming these inadequacies by equipping them with a clear picture of what IH is and the poor QoL outcomes it is associated with. Please join expert faculty in a discussion on how to better recognize the significant impact of IH symptoms on QoL.
In this CMEO Snack entitled, Ground Broken: Novel Therapies to Manage Idiopathic Hypersomnia, expert faculty will discuss current and novel therapies in IH, efficacy and safety data from recent clinical trials, and relevant findings from the SLEEP 2023 conference.
In this CMEO BriefCase activity, join expert faculty Dr. Thorpy and Dr. Morse for a discussion on best practices to integrate appropriate assessments and tools to facilitate early diagnosis of IH.
Please join Dr. Foldvary-Schaefer in this adaptive learning activity for a personalized journey through the latest clinical evidence for IH, strategies to transition patients to new therapies, and evidence-based tools to assess symptom severity and treatment effectiveness.